1. Home
  2. STEL vs AGIO Comparison

STEL vs AGIO Comparison

Compare STEL & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STEL
  • AGIO
  • Stock Information
  • Founded
  • STEL 2007
  • AGIO 2007
  • Country
  • STEL United States
  • AGIO United States
  • Employees
  • STEL N/A
  • AGIO N/A
  • Industry
  • STEL Major Banks
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • STEL Finance
  • AGIO Health Care
  • Exchange
  • STEL Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • STEL 1.3B
  • AGIO 1.4B
  • IPO Year
  • STEL N/A
  • AGIO 2013
  • Fundamental
  • Price
  • STEL $26.32
  • AGIO $27.32
  • Analyst Decision
  • STEL Hold
  • AGIO Buy
  • Analyst Count
  • STEL 3
  • AGIO 8
  • Target Price
  • STEL $29.00
  • AGIO $56.00
  • AVG Volume (30 Days)
  • STEL 214.5K
  • AGIO 515.6K
  • Earning Date
  • STEL 04-25-2025
  • AGIO 05-01-2025
  • Dividend Yield
  • STEL 2.14%
  • AGIO N/A
  • EPS Growth
  • STEL N/A
  • AGIO N/A
  • EPS
  • STEL 2.12
  • AGIO 11.45
  • Revenue
  • STEL $430,733,000.00
  • AGIO $37,035,000.00
  • Revenue This Year
  • STEL $1.97
  • AGIO $40.62
  • Revenue Next Year
  • STEL $4.52
  • AGIO $216.26
  • P/E Ratio
  • STEL $12.49
  • AGIO $2.42
  • Revenue Growth
  • STEL N/A
  • AGIO 25.96
  • 52 Week Low
  • STEL $21.27
  • AGIO $23.42
  • 52 Week High
  • STEL $32.36
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • STEL 52.66
  • AGIO 41.34
  • Support Level
  • STEL $25.48
  • AGIO $27.78
  • Resistance Level
  • STEL $26.62
  • AGIO $31.55
  • Average True Range (ATR)
  • STEL 0.76
  • AGIO 1.38
  • MACD
  • STEL 0.15
  • AGIO -0.03
  • Stochastic Oscillator
  • STEL 59.45
  • AGIO 2.98

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc.; and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: